P2B-136

Epworth HealthCare Clinical Trials and Research Centre (Richmond, Australia) › P2B-136

P2B-136

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Epworth HealthCare Clinical Trials and Research Centre (Richmond, Australia) · Dr. Dubois
consented 2013-07-17

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 constipation with onset in cycle 6 (2013-11-13); assessed as not related to study drug (not related); resolved 2013-11-15.

mild assessed

Grade 2 nausea with onset in cycle 4 (2013-10-01); assessed as not related to study drug (unlikely); resolved 2013-10-02.

moderate assessed

Grade 1 stomatitis with onset in cycle 1 (2013-08-02); assessed as related to study drug (probable); resolved 2013-08-09.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.